Showing 1191-1200 of 1970 results for "".
- Bausch Health Suspends Plans for Solta IPOhttps://modernaesthetics.com/news/bausch-health-suspends-plans-for-solta-ipo-1/2473255/Bausch Health Companies Inc. is suspending its plans for the Solta IPO due to challenging market conditions and other factors. Bausch Health stated that the interests of the Company's stakeholders are best served in the near-term by focusing on driving Solta's revenue, profits a
- Apyx Medical Corporation Scores FDA 510(k) Clearance for Renuvion Handpiecehttps://modernaesthetics.com/news/apyx-medical-corporation-scores-fda-510k-clearance-for-renuvion-handpiece/2473245/The U.S. Food and Drug Administration has granted marketing clearance to Apyx Medical Corporation’s Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to
- ISHRS Survey: Surgical Advances; Improvements in Efficiency Driving Need for Fewer Hair Transplant Treatmentshttps://modernaesthetics.com/news/ishrs-survey-surgical-advances-improvements-in-efficiency-driving-need-for-fewer-hair-transplant-treatments/2473235/According to results of a new member survey conducted by the International Society of Hair Restoration Surgery (ISHRS), 68 percent of members reported performing an average of one procedure per patient in 2021 to achieve the desired hair restoration result. This represents a significant improveme
- CellFX from Pulse Biosciences Shows Durable Effects for Sebaceous Hyperplasia: ASLMS Presentationhttps://modernaesthetics.com/news/cellfx-from-pulse-biosciences-shows-durable-effects-for-sebaceous-hyperplasia-aslms-presentation/2473233/The CellFX® system from Pulse Biosciences, Inc. demonstrates durable efficacy for the clearance of Sebaceous Hyperplasia lesions, according to data presented at the 2022
- Study: Sick Patients Get Cosmetic Surgery to Look Healthierhttps://modernaesthetics.com/news/study-sick-patients-get-cosmetic-surgery-to-look-healthier/2473216/Patients dealing with serious illnesses may want cosmetic procedures to make them look healthier, reports a small new Northwestern Medicine study. The patients believe cosmetic surgery may help them feel better in social situations with their friends, family or when they’re at work. &n
- This National Peel Day, PCA Skin Asks, #HowYouPeelinhttps://modernaesthetics.com/news/this-national-peel-day-pca-skin-asks-howyoupeelin/2473206/PCA SKIN® wants to know #HowYouPeelin, as the company celebrates the third annual National Peel Day, Thursday, highlighting their latest peel innovation, new partnership, special promotion for accounts, and a host of social media activities. National Peel Day is recognize
- The Beauty Health Company Introduces HydraFacial Syndeo Delivery Systemhttps://modernaesthetics.com/news/the-beauty-health-company-introduces-hydrafacial-syndeo-delivery-system/2473205/The Beauty Health Company is rolling out the HydraFacial Syndeo, a digital device that aims to enhance the consumer and provider experience. “As a category creator, we deliver beauty health experiences every day that re-invent our consumer’s relationship with their ski
- Hallura’s New BiOLinkMatrix HA Aesthetic Dermal Fillers Perform Well in Lips, Cheeks, and Smile Lineshttps://modernaesthetics.com/news/halluras-new-biolinkmatrix-ha-aesthetic-dermal-fillers-performs-well-in-lips-cheeks-and-smile-lines/2473203/Hallura Ltd’s hyaluronic acid (HA) dermal fillers with its proprietary BiOLinkMatrix platform performed well for lip enhancement, nasolabial folds correction. and cheek enhancement, according to topline results. The pro
- FDA Approves Juvederm Volbella XC for Undereye Hollowshttps://modernaesthetics.com/news/fda-approves-juvederm-volbella-xc-for-undereye-hollows/2473194/FDA has given its nod to Allergan Aesthetics, Juvederm Volbella XC for improvement of infraorbital hollows in adults over the age of 21. Per FDA requirement for this new indication, Allergan Aesthetics is providing a product training program for all interested providers, whic
- Done Deal: RoundTable Healthcare Partners Completes Sale of Revision Skincare and Goodier Cosmetics to Gryphon Investorshttps://modernaesthetics.com/news/done-deal-roundtable-healthcare-partners-completes-sale-of-revision-skincare-and-goodier-cosmetics-to-gryphon-investors/2473172/RoundTable Healthcare Partners completed the previously announced sale of Revision Skincare and Goodier Cosmetics to Gryphon Investors. Terms of the transaction were not disclosed. Revision Skincare’s portfolio includes Nectifirm, Intellishade, D·E·J